High attrition rate with intracavernousinjection of prostaglandin E1 for impotency
- 31 January 1994
- Vol. 43 (1), 84-87
- https://doi.org/10.1016/s0090-4295(94)80272-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Twelve-month comparison of two treatments for erectile dysfunction: Self-injection versus external vacuum devicesUrology, 1992
- A Lethal Complication of Papaverine-Induced PriapismJournal of Urology, 1991
- Intracavernous Injection of Prostagland in E1 in combination With Papaverine: Enhanced Effectiveness in Comparison With Papaverine Plus Phentolamine and Prostaglandin E1 AloneJournal of Urology, 1991
- Intracavernous Injection Therapy: Analysis of Results and ComplicationsJournal of Urology, 1990
- Side Effects of Self-Administration of Intracavernous Papaverine and Phentolamine for the Treatment of ImpotenceJournal of Urology, 1989
- Intracavernous Injection of Prostaglandin E1 in Impotent MenJournal of Urology, 1988
- Clinical experience with vasoactive intracavernous pharmacotherapy for treatment of impotenceWorld Journal of Urology, 1987
- Fibrosis of Corpus Cavernosum After Intracavernous Injection of Phentolamine/PapaverineJournal of Urology, 1987
- Contraction and Relaxation Induced by Some Prostanoids in Isolated Human Penile Erectile Tissue and Cavernous ArteryJournal of Urology, 1985
- Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile ImpotenceThe British Journal of Psychiatry, 1983